Immunoadhesins: principles and applications
Data up to Jan 2025
Total Citations Per Year
Abstract
References (83)
The Fas Death Factor
1995 • 4,070 citations
Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
1993 • 2,546 citations
CD44 is the principal cell surface receptor for hyaluronate
1990 • 2,433 citations
Phage antibodies: filamentous phage displaying antibody variable domains
1990 • 2,346 citations
CTLA-4 is a second receptor for the B cell activation antigen B7.
1991 • 1,662 citations
Reshaping human antibodies for therapy
1988 • 1,555 citations
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
1994 • 1,328 citations
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
1991 • 1,132 citations
Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
1994 • 1,104 citations
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases
1995 • 704 citations
An endothelial ligand for L-Selectin is a novel mucin-like molecule
1992 • 660 citations
Binding of L-Selectin to the Vascular Sialomucin CD34
1993 • 629 citations
Designing CD4 immunoadhesins for AIDS therapy
1989 • 612 citations
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
1993 • 541 citations
The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.
1992 • 518 citations
Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins
1995 • 381 citations
Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
1995 • 375 citations
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
1995 • 368 citations
Antigen–specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs
1994 • 351 citations
The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2–6 sialyltransferase, CD75, on B cells
1991 • 348 citations
Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor
1993 • 328 citations
A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.
1991 • 326 citations
Identification of a carbohydrate-based endothelial ligand for a lymphocyte homing receptor.
1991 • 308 citations
Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice.
1993 • 298 citations
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
1994 • 284 citations
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor
1993 • 280 citations
Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation
1995 • 261 citations
CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin.
1993 • 243 citations
Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes
1991 • 242 citations
Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide‐induced lethality
1991 • 239 citations
Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules
1989 • 217 citations
Biological properties of a CD4 immunoadhesin
1990 • 176 citations
Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation.
1995 • 171 citations
A soluble chimeric form of the L1 glycoprotein stimulates neurite outgrowth
1995 • 168 citations
A homing receptor-IgG chimera as a probe for adhesive ligands of lymph node high endothelial venules.
1990 • 162 citations
Conserved domain structure of beta-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins.
1994 • 157 citations
Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera.
1991 • 140 citations
A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
1993 • 122 citations
Protective effects of selectin chimeras in neutrophil-mediated lung injury.
1993 • 122 citations
Characterization of Sialyloligosaccharide Binding by Recombinant Soluble and Native Cell-associated CD22
1995 • 119 citations
Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts.
1995 • 110 citations
Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells.
1992 • 95 citations
Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus
1994 • 90 citations
VLA-4 integrin mediates lymphocyte migration on the inducible endothelial cell ligand VCAM-1 and the extracellular matrix ligand fibronectin.
1993 • 90 citations
Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules
1993 • 87 citations
CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
1992 • 85 citations
Binding of Sialyl Lewis X to E-Selectin As Measured by Fluorescence Polarization
1995 • 79 citations
Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes.
1994 • 75 citations
Analysis of the Binding Site on Intercellular Adhesion Molecule 3 for the Leukocyte Integrin Lymphocyte Function-associated Antigen 1
1995 • 75 citations
Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins. Effects of mutations in the potential proteolytic cleavage site on processing and ligand binding.
1992 • 74 citations
Expression and Characterization of Human CD4: Immunoglobulin Fusion Proteins
1990 • 73 citations
Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule.
1994 • 70 citations
Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera.
1995 • 66 citations
Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding.
1992 • 61 citations
A chimeric IL-2/Ig molecule possesses the functional activity of both proteins.
1991 • 52 citations
The Disulfide Linkages and Glycosylation Sites of the Human Natriuretic Peptide Receptor-C Homodimer
1994 • 50 citations
The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL‐6 and the IL‐6 receptor
1995 • 49 citations
Production of lymphotoxin (LTα) and a soluble dimeric form of its receptor using the baculovirus expression system
1994 • 45 citations
A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis.
1992 • 43 citations
Location of gp330/alpha 2-m receptor-associated protein (alpha 2-MRAP) and its binding sites in kidney: distribution of endogenous alpha 2-MRAP is modified by tissue processing.
1993 • 43 citations
Immunoadhesins
1993 • 41 citations
Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo.
1993 • 38 citations
IFN-gamma receptor-Ig fusion proteins. Half-life, immunogenicity, and in vivo activity.
1992 • 38 citations
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex
1991 • 37 citations
A Humanized, Bispecific Immunoadhesin-Antibody that Retargets CD3+ Effectors to Kill HIV-1-Infected Cells
1995 • 35 citations
Construction, purification, and characterization of new interferon gamma (IFN gamma) inhibitor proteins. Three IFN gamma receptor-immunoglobulin hybrid molecules.
1992 • 31 citations
Enzymic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments
1990 • 31 citations
A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.
1994 • 30 citations
Soluble intercellular adhesion molecule 1-immunoglobulin G1 immunoadhesin mediates phagocytosis of malaria-infected erythrocytes.
1992 • 26 citations
HER4 Receptor Activation and Phosphorylation of Shc Proteins by Recombinant Heregulin-Fc Fusion Proteins
1995 • 25 citations
β PDGFR‐IgG chimera demonstrates that human β PDGFR Ig‐like domains 1 to 3 are sufficient for high affinity PDGF BB binding
1995 • 24 citations
TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells
1994 • 23 citations
Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin.
1993 • 17 citations
Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavage
1994 • 16 citations
Identification of the T cell surface signal‐transducing glycoprotein sgp‐60 as CD48, a counter‐receptor for mouse CD2
1993 • 15 citations
Immunoadhesins: An Alternative to Human Monoclonal Antibodies
1995 • 14 citations
Molecular and biological properties of an interleukin-1 receptor immunoadhesin
1994 • 13 citations
Recombinant globulins: novel research tools and possible pharmaceuticals
1992 • 12 citations
Effects of Chemical Modification on the Binding Activities of P-Selectin Mutants
1995 • 11 citations
Bispecific receptor globulins, novel tools for the study of cellular interactions
1993 • 10 citations
Human erythropoietin-specific sites of monoclonal antibody-mediated neutralization
1993 • 9 citations
Recombinant CD4‐IgE, a novel hybrid molecule, inducing basophils to respond to human immunodeficiency virus (HIV) and HIV‐infected target cells
1995 • 6 citations
Coengagement of CD2 with LFA-1 or VLA-4 by bispecific ligand fusion proteins primes T cells to respond more effectively to T cell receptor-dependent signals
1994 • 5 citations
Cited By (0)
No citing papers found in database